Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesterase.
D000818:Animals; D001921:Brain / Q000201:enzymology; D003994:Bucladesine / Q000494:pharmacology; D002415:Cats; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000494:pharmacology; D003597:Cytosine Nucleotides / Q000494:pharmacology; D006868:Hydrolysis; D066298:In Vitro Techniques; D007292:Inosine Nucleotides / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009206:Myocardium / Q000201:enzymology; D009712:Nucleotides, Cyclic / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D051381:Rats; D014316:Tritium; D014500:Uracil Nucleotides / Q000494:pharmacology
D003597:Cytosine Nucleotides; D007292:Inosine Nucleotides; D009712:Nucleotides, Cyclic; D010726:Phosphodiesterase Inhibitors; D014500:Uracil Nucleotides; D014316:Tritium; D003994:Bucladesine; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D006152:Cyclic GMP